| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Azeliragon |
|---|
| Description | Azeliragon is a potent RAGE (the receptor for advanced glycation end products) inhibitor. It has been evaluated for potential treatment for patients with mild-to-moderate Alzheimer's disease (AD). Azeliragon decreases brain amyloid in mice and improves their performance on behavior tests. Azeliragon is a promising agent for for Alzheimer's disease and cerebral amyloid angiopathy. MW: 532.12. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1H-imidazol-4-yl)phenoxy)-N,N-diethylpropan-1-amine; TTP488; TTP-488 |
|---|
| Gene, Accession, CAS # | CAS: 603148-36-3 |
|---|
| Catalog # | B1152-25 |
|---|
| Price | |
|---|
| Order / More Info | Azeliragon from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|